Boston Scientific reports positive SIMPLAAFY trial results

Boston Scientific announced positive results from its SIMPLAAFY clinical trial, which randomized 1,857 patients across 86 U.S. sites. Imaging at 45 days indicated a lower rate of device-related thrombus in patients on the reduced-dose NOAC regimen compared to DAPT.

Detected & updated continuously · Source: Nebula